The traditional pharmaceutical commercial model was built for a market that no longer exists. Greater scrutiny of value, more complex customer relationships, new channels of engagement and mounting pressure on margins are forcing companies to reconsider how they organize, invest and compete.

But recognizing the need for change is easier than executing it. Which elements of the traditional model are being reconsidered? Where are companies making meaningful progress—and what continues to stand in the way?

Numerof & Associates conducted field research with pharmaceutical industry executives to understand how commercial models are changing, what is driving those decisions and where organizations are placing their bets for the future.

The findings reveal an industry actively rewriting its commercial playbook—but not always with the same priorities, pace or definition of success.

Download the report to get insight into important topics, including:

• The market forces creating the greatest pressure for commercial change
• Where companies are rethinking established structures, roles and ways of working
• The capabilities and investments executives view as increasingly important
• The organizational barriers that continue to slow commercial adaptation
• How industry leaders are defining the next generation of commercial success

DOWNLOAD THE REPORT